DHR Danaher Corporation
Trend channel, buy level and 3-month target. Information only, not financial advice.
Inside the channel Β· 9-month channel rising
Price is between the lines.
- 9-month channel
- US$216.92 β US$238.57 Β· rising, +27% a year
- Price in channel
- 71% (0% = floor, 100% = ceiling)
- Ceiling overhead
- US$238.57
- Turns bearish below
- US$216.92
- Published levels
- Buy and target are not from this channel β see below.
Price history, with the path projected 3 months forward
Updated 7:53 AM ET (3 h ago)
- Daily close
- Upper trend line (9 months)
- Lower trend line (9 months)
- Dashed after today: projected 3 months
- Our buy
- Our target
Our target
Hit rate too low on this symbol (2/9) β no published call or alerts; levels below are for reference.
Buy at or below
US$212.72
level as at 10 Dec 2026
Our target
US$238.24
by 4 Nov 2026
Projected move
12.0%
gross, before costs
Price is between our buy and target.
Target: DHR's usual move size (12.0%), the best return per day on this path.
9 settled calls Β· 2 reached target (22.2%) Β· average best move 6.9%. See the full record.
- Upper line touches
- 3
- Lower line touches
- 3
- Fit confidence
- 82%
- Fitted
- 1 Nov 2026
Company information
About Danaher Corporation
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water typesβincluding ultra-pure, potable, industrial, waste, ground, source, and ocean waterβacross residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Julie Sawyer Montgomery
- Employees
- 59,000
- Country
- US
Scorecard
Our own scores from the fundamentals below (not Morningstar ratings).
- Valuation
- β
- Profitability
- β
- Financial health
- β
- Cash generation
- β
Key statistics
- Market cap
- US$163.16B
- Enterprise value
- β
- Beta
- 0.80
- Avg volume
- 4.74M
- Revenue per share
- β
- Dividend yield
- β
- 52-week range
- 160.93-242.8
- Exchange
- NYSE
Key ratios
- P/E (TTM)
- β
- PEG
- β
- Price / sales
- β
- Price / book
- β
- EV / EBITDA
- β
- Gross margin
- β
- Operating margin
- β
- Net margin
- β
- Current ratio
- β
- Quick ratio
- β
- Debt / equity
- β
- Interest cover
- β
Income statement
Balance sheet
Cash flow
Trend lines are fitted to past swing highs and lows and may not continue. Information only, not financial advice.